|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.02 EUR | -0.03% |
|
+3.40% | +12.24% |
| 07-23 | Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.05B | |||||
| 50.03B | |||||
| 44.36B | - | - | - | - | - |
| 40.82B | |||||
| 39.83B | |||||
| 32.51B |
- Stock Market
- Stocks
- ERF Stock
- Charts Eurofins Scientific SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
